Asymptomatic infection by influenza AH1N1 virus in healthcare workers. MARBEGRIP study, preliminar results;Infección asintomática por elvirus influenza H1N1(2009) en personal sanitario. Estudio MARBEGRIP. Resultados preliminares

Revista Espanola de Salud Publica

Volumn 85, Issue 1, 2011, Pages 63-71

  Sierra, Julián Olalla ^a,b   De Ory Manchón, Fernando ^b,c   Flecha, Inmaculada Casas ^c   Quezel Guerraz, Natalia Montiel ^a   Bravo, Daniel Salas ^d  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Distrito Sanitario de la Costa Del Sol   (Spain)

Author keywords

Health personnel; Hemag glutination inhibition; Human influenza; Prevalence

Indexed keywords

ARTICLE; ASYMPTOMATIC INFECTION; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; PREVALENCE; PROSPECTIVE STUDY;

ASYMPTOMATIC INFECTIONS; HEALTH PERSONNEL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PREVALENCE; PROSPECTIVE STUDIES;

EID: 79960219759     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: 10.1590/S1135-57272011000100008     Document Type: Article

References (16)

1. World Health Organization 2. Global alert and response: Pandemic (H1N1). Geneva: World Health Organization; 2009. Disponible en: http://www.who.int/csr/ disease/swineflu/en).
2. United States Centers for Disease Control and Prevention. Interim guidance for clinicians on identifying and caring for patients with swine-origin influenzaA(H1N1) virus infection.Atlanta, Centers for Disease Control and Prevention; 2010. Disponible en: http://wwwcdcgov/swineflu/ identifyingpatientshtm.
3. Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenzaAH1N1 infection in England: an observational population-based study. Lancet. 2010 Oct 26. [Epub ahead of print].
4. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med. 2009; 360: 2616-2625.
5. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009; 374(9688): 451-458.
6. Viasus D, Paño-Pardo JR, Pachón J, Campins A, López-Medrano F, VillosladaA, et al. Factors associated with severe disease in hospitalised adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect. 2010 Sep 3. doi: 10.1111/j.1469-0691.2010.03362.x. [Epub ahead of print].
7. Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.MorbMortalWkly Rep. 2009; 58: 453-458.
8. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts andmixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3): e74.
9. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010; 375(9720): 1100-1108.
10. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009; 361: 2405-2413.
11. Serum cross-reactive antibody response to a novel influenzaA(H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep. 2009; 58: 521-524.
12. KendalAP, PereiraMS, Skehel JJ. Concepts and procedures for laboratory based influenza surveillance. Atlanta: Centers for Disease Control, 1982.
13. Peña-Rey I, Martínez de Aragón V, Mosquera M, de Ory F, Echevarría JE, Measles Elimination Plan Working Group in Spain. Measles risk groups in Spain: implications for the European measles-elimination target. Vaccine. 2009; 27: 3927-3934.
14. Raude J, Caille-BrilletAL, SetbonM. The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr. 2010; 2: RRN1188.
15. Savas E, Tanriverdi D. Knowledge, attitudes and anxiety towards influenza A/H1N1 vaccination of healthcare workers in Turkey. BMC Infect Dis. 2010; 10: 281.
16. Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet. 2010; 375(9708): 49-55.